Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
18.32
+0.06 (0.33%)
Mar 27, 2026, 3:00 PM CST
SHA:600529 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,074 | 1,065 | 1,466 | 1,352 | 885.04 |
Trading Asset Securities | 1,671 | 1,725 | 1,218 | 1,101 | 307.13 |
Cash & Short-Term Investments | 2,745 | 2,790 | 2,684 | 2,453 | 1,192 |
Cash Growth | -1.62% | 3.95% | 9.40% | 105.80% | -12.49% |
Accounts Receivable | 1,486 | 1,732 | 1,701 | 1,551 | 1,200 |
Other Receivables | 2.06 | 1.87 | 1.78 | 2.24 | 3.38 |
Receivables | 1,489 | 1,734 | 1,703 | 1,553 | 1,203 |
Inventory | 1,696 | 1,279 | 1,055 | 1,210 | 877.74 |
Other Current Assets | 82.88 | 177.99 | 103.8 | 104.63 | 61.99 |
Total Current Assets | 6,012 | 5,980 | 5,546 | 5,321 | 3,335 |
Property, Plant & Equipment | 3,678 | 3,786 | 3,465 | 2,821 | 2,557 |
Long-Term Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Other Intangible Assets | 241.97 | 247.24 | 253.67 | 260.37 | 198.37 |
Long-Term Deferred Tax Assets | 91.79 | 74.46 | 37.8 | 32.01 | 32.42 |
Other Long-Term Assets | 19.79 | 51.73 | 16.79 | 349.91 | 287.01 |
Total Assets | 10,044 | 10,140 | 9,319 | 8,784 | 6,410 |
Accounts Payable | 1,208 | 1,583 | 1,394 | 1,418 | 1,436 |
Accrued Expenses | 211.77 | 209.47 | 149.8 | 130.47 | 126.18 |
Short-Term Debt | - | - | 1.83 | 5.2 | - |
Current Portion of Leases | 14.11 | - | - | - | - |
Current Income Taxes Payable | 8.68 | 30.25 | 16.65 | 14.87 | 15.25 |
Current Unearned Revenue | 56.65 | 60 | 61.79 | 51.04 | 74.61 |
Other Current Liabilities | 101.96 | 118.07 | 102.83 | 144.13 | 27.74 |
Total Current Liabilities | 1,601 | 2,001 | 1,727 | 1,764 | 1,679 |
Long-Term Leases | 23.4 | - | - | - | - |
Long-Term Unearned Revenue | 124.53 | 131.67 | 57.62 | 58.95 | 59.97 |
Total Liabilities | 1,749 | 2,132 | 1,784 | 1,823 | 1,739 |
Common Stock | 663.61 | 663.61 | 663.61 | 663.61 | 594.97 |
Additional Paid-In Capital | 2,687 | 2,687 | 2,687 | 2,687 | 913.45 |
Retained Earnings | 4,882 | 4,591 | 4,112 | 3,535 | 3,096 |
Comprehensive Income & Other | 61.81 | 66.39 | 71.59 | 75.48 | 66.22 |
Total Common Equity | 8,295 | 8,008 | 7,535 | 6,962 | 4,670 |
Shareholders' Equity | 8,295 | 8,008 | 7,535 | 6,962 | 4,670 |
Total Liabilities & Equity | 10,044 | 10,140 | 9,319 | 8,784 | 6,410 |
Total Debt | 37.5 | - | 1.83 | 5.2 | - |
Net Cash (Debt) | 2,708 | 2,790 | 2,682 | 2,448 | 1,192 |
Net Cash Growth | -2.96% | 4.02% | 9.56% | 105.36% | -12.49% |
Net Cash Per Share | 4.08 | 4.20 | 4.05 | 4.08 | 2.00 |
Filing Date Shares Outstanding | 663.61 | 663.61 | 663.61 | 663.61 | 594.97 |
Total Common Shares Outstanding | 663.61 | 663.61 | 663.61 | 663.61 | 594.97 |
Working Capital | 4,411 | 3,980 | 3,819 | 3,557 | 1,656 |
Book Value Per Share | 12.50 | 12.07 | 11.35 | 10.49 | 7.85 |
Tangible Book Value | 8,053 | 7,761 | 7,281 | 6,701 | 4,472 |
Tangible Book Value Per Share | 12.13 | 11.69 | 10.97 | 10.10 | 7.52 |
Buildings | 2,271 | 2,149 | 1,911 | 1,507 | 1,402 |
Machinery | 3,632 | 3,426 | 2,745 | 983.08 | 2,004 |
Construction In Progress | 71.04 | 215.36 | 470.14 | 475.18 | 342.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.